CD200R is also expressed on the microglia and recent study demonstrated that, in a model of middle cerebral artery occlusion, intravenous-injected BM-MSCs inactivate the microglia in the peri-infarct area via CD200-CD200R signaling pathway and reduce the volume of the infarct zone (75). This evidence concerns the gene CD200R1 and medical procedure.